Optimal Dose of Remimazolam for Sedation During Spinal Anesthesia in Age 60+: A Preliminary Study

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0007075

Enrollment

Registered

2022-03-11

Start date

2022-03-09

Completion date

Unknown

Last updated

2022-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug : This study is a single, open, one-arm study, there is no control group, and blinding is not performed.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patients who agreed to the clinical trial and scheduled for orthopedic surgery under spinal anesthesia 2. Patients over 60 years of age, ASA physical status classification system I-III

Exclusion criteria

Exclusion criteria: 1. Patients who do not consent to clinical trials 2. Patients with spinal anesthesia level higher than T6 3. Patient with previous spine surgery 4. Patients with body mass index (BMI) 30 kg/m2 5. Patients who are chronic alcoholics or who are taking psychiatric medications for a long time 6. Patients with a history of allergy to previous general anesthetics, patients with hypersensitivity to other benzodiazepines

Design outcomes

Primary

Measure	Time frame
maintenance dose of remimazolam	—

Secondary

Measure	Time frame
Types and doses of rescue drugs used during surgery;Respiratory suppression;Blood Pressure;heart rate	—

Countries

Korea, Republic of

Contacts

Public ContactHyunyoung Seong

Korea University Anam Hospital

hello406@naver.com+82-2-920-5632

Outcome results